ArticleArchives of medical science : AMS2023

Eligibility for icosapent ethyl in a French population of coronary outpatients with type 2 diabetes.

Pierre François Sabouret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.